Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Parkinson's Disease
NCT07229651Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Nov 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of metformin in Parkinson's disease (PD) (2 arms), sponsored by Tanta University. Primary endpoint: Unified Parkinson's Disease Rating Scale at 6 months. Started Nov 2025; status: recruiting.
02
Drugs
metformin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07229651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07229651.